Mangoceuticals, Inc. (MGRX)

Mangoceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Cap	25	8	6	61
Market Cap Growth	252.03%	26.16%	-89.84%	-
Enterprise Value	24.03	7.94	5.55	60.87
Last Close Price	2.20	2.42	4.36	60.00
PE Ratio	-	-0.50	-0.51	-21.05
PS Ratio	20.19	12.75	8.51	6853.12
PB Ratio	1.20	0.56	8.04	99.77
P/TBV Ratio	0.55	0.34	6.05	70.34
P/FCF Ratio	-	-1.61	-0.89	-44.08
P/OCF Ratio	-	-1.61	-0.89	-45.50
EV/Sales Ratio	46.57	12.90	7.59	6809.85
EV/EBITDA Ratio	-	-1.10	-0.60	-30.62
EV/EBIT Ratio	-	-1.00	-0.60	-30.57
EV/FCF Ratio	-	-1.63	-0.79	-43.81
Debt / Equity Ratio	0.03	0.01	0.08	0.48
Debt / EBITDA Ratio	-0.05	-0.03	-0.01	-0.18
Debt / FCF Ratio	-0.11	-0.04	-0.02	-0.25
Asset Turnover	0.03	0.08	0.71	0.01
Inventory Turnover	-	25.50	32.43	-
Quick Ratio	0.06	0.04	3.50	2.62
Current Ratio	0.07	0.05	3.96	2.67
Return on Equity (ROE)	-85.60%	-118.31%	-1326.69%	-325.40%
Return on Assets (ROA)	-74.88%	-97.09%	-897.62%	-198.51%
Return on Capital (ROIC)	-72.48%	-98.65%	-2270.73%	-373.75%
Return on Capital Employed (ROCE)	-81.70%	-107.84%	-1165.16%	-268.15%
Earnings Yield	-64.14%	-200.00%	-196.79%	-4.75%
FCF Yield	-24.79%	-61.92%	-112.45%	-2.27%
Buyback Yield / Dilution	0.00%	-16.91%	-116.04%	-3.26%
Total Shareholder Return	-	-16.91%	-116.04%	-3.26%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q